CS logo
small CS logo
Juno Research, LLC

Houston, Texas, United States
Drug testing service in Houston, Texas
607 Mason Rd, Katy, TX 77450

About Juno Research, LLC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Juno Research, LLC


During the past decade, Juno Research, LLC conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 13 clinical trials were completed, i.e. on average, 46.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 9 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44222233222277660000331100111166Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
2006-05-01
2008-12-01
Completed
1,306
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
2009-04-01
2010-05-01
Completed
1,093
A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)
2008-02-01
2010-08-01
Completed
161
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
2010-10-01
2011-10-01
Terminated
196
Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes
2010-03-01
2010-12-01
Completed
509
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
2010-10-01
2012-01-01
Completed
218
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
2011-11-01
2013-10-01
Completed
465
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
2012-06-01
2013-10-01
Completed
442

Rows per page:

1–39 of 39

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Juno Research, LLC" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Pfizer" with 5 trials sponsored, "Ionis Pharmaceuticals, Inc." with 4 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Juno Research, LLC" #1 collaborator was "Integrium" with 2 trials as a collaborator, "Barc NV" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Haupt Pharma Wülfing GmbH" with 1 trials as a collaborator and "Kinexum LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 10Eli Lilly and Company: 10Pfizer: 5Pfizer: 5Ionis Pharmaceuticals, Inc.: 4Ionis Pharmaceuticals, Inc.: 4AstraZeneca: 2AstraZeneca: 2Gilead Sciences: 2Gilead Sciences: 2Intarcia Therapeutics: 2Intarcia Therapeutics: 2Kowa Research Institute, Inc.: 2Kowa Research Institute, Inc.: 2Aggredyne, Inc.: 1Aggredyne, Inc.: 1BHV Pharma: 1BHV Pharma: 1Elcelyx Therapeutics, Inc.: 1Elcelyx Therapeutics, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsIntegrium: 2Integrium: 2Barc NV: 1Barc NV: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Haupt Pharma Wülfing GmbH: 1Haupt Pharma Wülfing GmbH: 1Kinexum LLC: 1Kinexum LLC: 1Msource MedicalDevelopment GmbH: 1Msource MedicalDevelopment GmbH: 1Mylan GmbH: 1Mylan GmbH: 1Thermo Fisher Scientific, Inc: 1Thermo Fisher Scientific, Inc: 1University of Kentucky: 1University of Kentucky: 1

Clinical Trials Conditions at Juno Research, LLC


According to Clinical.Site data, the most researched conditions in "Juno Research, LLC" are "Type 2 Diabetes Mellitus" (9 trials), "Type 2 Diabetes" (8 trials), "Diabetes Mellitus, Type 2" (5 trials), "Diabetes" (4 trials) and "Obesity" (4 trials). Many other conditions were trialed in "Juno Research, LLC" in a lesser frequency.

Clinical Trials Intervention Types at Juno Research, LLC


Most popular intervention types in "Juno Research, LLC" are "Drug" (35 trials), "Other" (7 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Insulin Degludec" (4 trials), "Metformin" (4 trials), "Tirzepatide" (4 trials) and "Diet" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Juno Research, LLC


The vast majority of trials in "Juno Research, LLC" are 39 trials for "All" genders.

Clinical Trials Status at Juno Research, LLC


Currently, there are NaN active trials in "Juno Research, LLC". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Juno Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Juno Research, LLC, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 18Phase 3: 18Phase 2: 16Phase 2: 16Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 31Completed: 31Active, not recruiting: 4Active, not recruiting: 4Recruiting: 2Recruiting: 2Terminated: 2Terminated: 2